Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J de Castro

Showing results (231-240 of 266) with videos related to

Pageof 27
Sort By:
British Journal of Cancer|March 23, 2006
XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancerJ Feliu, A Salud, P Escudero, et al.
Oncogene|February 8, 2006
MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancerS Chattopadhyay, R Machado-Pinilla, C Manguan-García, et al.
Current Cancer Drug Targets|January 11, 2012
Analysis of the concordance in the EGFR pathway status between primary tumors and related metastases of colorectal cancer patients:implications for cancer therapyP Cejas, M López-Gómez, C Aguayo, et al.
ESMO Open|January 18, 2022
Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancerJ Wolf, Å Helland, I-J Oh, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 23, 2020
Prognostic value of neutrophil-to-lymphocyte ratio in advanced cancer patients receiving immunotherapyD Viñal, L Gutierrez-Sainz, D Martinez, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 16, 2011
Influence of resting energy expenditure on weight gain in adolescents taking second-generation antipsychoticsCristina Cuerda, Jessica Merchan-Naranjo, Cristina Velasco, et al.
Pain|September 9, 2008
Analgesic effect in rodents of native and recombinant Ph alpha 1beta toxin, a high-voltage-activated calcium channel blocker isolated from armed spider venomAlessandra H Souza, Juliano Ferreira, Marta do Nascimento Cordeiro, et al.
Infection|November 20, 2014
Malignant syphilis in an AIDS patientT R dos Santos, I J de Castro, M M B Dahia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2018
Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR studyS Novello, J Mazières, I-J Oh, et al.
International Journal of Clinical Practice|August 22, 2013
Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE)C Mathieu, A H Barnett, H Brath, et al.
Pageof 27

Showing results (231-240 of 266) with videos related to

Sort By:
Pageof 27
British Journal of Cancer|March 23, 2006
XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancerJ Feliu, A Salud, P Escudero, et al.
Oncogene|February 8, 2006
MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancerS Chattopadhyay, R Machado-Pinilla, C Manguan-García, et al.
Current Cancer Drug Targets|January 11, 2012
Analysis of the concordance in the EGFR pathway status between primary tumors and related metastases of colorectal cancer patients:implications for cancer therapyP Cejas, M López-Gómez, C Aguayo, et al.
ESMO Open|January 18, 2022
Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancerJ Wolf, Å Helland, I-J Oh, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 23, 2020
Prognostic value of neutrophil-to-lymphocyte ratio in advanced cancer patients receiving immunotherapyD Viñal, L Gutierrez-Sainz, D Martinez, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 16, 2011
Influence of resting energy expenditure on weight gain in adolescents taking second-generation antipsychoticsCristina Cuerda, Jessica Merchan-Naranjo, Cristina Velasco, et al.
Pain|September 9, 2008
Analgesic effect in rodents of native and recombinant Ph alpha 1beta toxin, a high-voltage-activated calcium channel blocker isolated from armed spider venomAlessandra H Souza, Juliano Ferreira, Marta do Nascimento Cordeiro, et al.
Infection|November 20, 2014
Malignant syphilis in an AIDS patientT R dos Santos, I J de Castro, M M B Dahia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2018
Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR studyS Novello, J Mazières, I-J Oh, et al.
International Journal of Clinical Practice|August 22, 2013
Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE)C Mathieu, A H Barnett, H Brath, et al.
Pageof 27